These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16577626)

  • 1. Reversible Coagulation in Living Tissue: XII.
    Bancroft WD; Rutzler JE
    Proc Natl Acad Sci U S A; 1934 Sep; 20(9):501-9. PubMed ID: 16577626
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.
    Park HS; Gu J; You HJ; Kim JE; Kim HK
    Thromb Res; 2016 Feb; 138():103-107. PubMed ID: 26706311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
    Labberton L; Kenne E; Renné T
    Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ERalpha-mediated trans-activation of human coagulation factor XII gene by heteromeric transcription factor NF-Y.
    Farsetti A; Narducci M; Moretti F; Nanni S; Mantovani R; Sacchi A; Pontecorvi A
    Endocrinology; 2001 Aug; 142(8):3380-8. PubMed ID: 11459781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report 2 cases of congenital factor XII deficiency: a rare coagulation disorder.
    Kanjanapongkul S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S231-2. PubMed ID: 22043782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and mechanisms of surface-dependent coagulation factor XII activation.
    Terentyeva VA; Sveshnikova AN; Panteleev MA
    J Theor Biol; 2015 Oct; 382():235-43. PubMed ID: 26187095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocytes express blood coagulation factor XII (Hageman factor).
    Gordon EM; Gallagher CA; Johnson TR; Blossey BK; Ilan J
    J Lab Clin Med; 1990 Apr; 115(4):463-9. PubMed ID: 2324612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OBSERVATIN OF FACTOR XII AND FACTOR XII DEFICIENT PLASMA AT AN INTERFACE.
    ADAMS AL; VROMAN L
    Thromb Diath Haemorrh; 1965 Jun; 13():387-93. PubMed ID: 14347862
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anesthetic management of a patient with blood coagulation factor XII deficiency].
    Okuda T; Takita A; Ikemoto T; Fukuda I; Karasawa F; Satoh T
    Masui; 2001 May; 50(5):535-7. PubMed ID: 11424474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of an hereditary coagulation factor XII deficiency in a consanguineous pedigree].
    Zhang Y; Xie HX; Wang MS; Jin YH; Xie YS; Zheng FX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):666-9. PubMed ID: 22161101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DURATION OF LIFE OF THE HAGEMAN FACTOR (FACTOR XII)].
    JOSSO F; PROU-WARTELLE O; CHARLAS J
    Nouv Rev Fr Hematol; 1964; 4():454-6. PubMed ID: 14186229
    [No Abstract]   [Full Text] [Related]  

  • 14. MODERATE FACTOR XII DEFICIENCY.
    BOK J; VELTKAMP JJ; LOELIGER EA
    Thromb Diath Haemorrh; 1965 Mar; 13():8-11. PubMed ID: 14285982
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal venous thrombosis in a young patient with coagulation factor XII deficiency.
    Borrego-Sanz L; Santos-Bueso E; Sáenz-Francés F; Martínez-de-la-Casa JM; García-Feijoo J; Gegúndez-Fernández JA; García-Sánchez J
    Arch Soc Esp Oftalmol; 2014 Aug; 89(8):329-31. PubMed ID: 24269423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LIVER AND BLOOD COAGULATION. I. BEHAVIOR OF FACTOR XII (HAGEMAN), OF FACTOR X (STUART) AND OF FIBRINOGEN IN LIVER PATIENTS].
    BOLANDRINA E; SOARDI F
    Gazz Int Med Chir; 1964 Jan; 68():63-79. PubMed ID: 14123792
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of Factor XII in hemostasis and thrombosis: clinical implications.
    Renné T; Gailani D
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
    Müller F; Renné T
    Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
    Nickel KF; Labberton L; Long AT; Langer F; Fuchs TA; Stavrou EX; Butler LM; Renné T
    Thromb Res; 2016 May; 141 Suppl 2():S4-7. PubMed ID: 27207422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.